Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

391

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

September 8, 2021

Study Completion Date

September 8, 2021

Conditions
Atopic Dermatitis
Interventions
DRUG

Crisaborole Ointment

Crisaborole ointment 2%

DRUG

Crisaborole Placebo Vehicle

Placebo for crisaborole ointment

Trial Locations (39)

100044

Peking University People's Hospital, Beijing

100045

Beijing Children's Hospital, Capital Medical University, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

130021

The First hospital of Jilin University, Changchun

200040

Huashan Hospital Fudan University, Shanghai

200062

Children's Hospital of Shanghai, Shanghai

250022

Shandong Provincial Institute of Dermatology and Venereology & Shandong Provincial Hospital for Skin, Jinan

300052

Tianjin Medical University General Hospital, Tianjin

300120

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin

310009

Hangzhou Third Hospital, Hangzhou

310014

Zhejiang Provincial People's Hospital/Dermatology Department, Hangzhou

310016

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou

325000

The first Affiliated hospital of Wenzhou medical University, Wenzhou

400037

The Second Affiliated Hospital of Army Medical University,PLA, Chongqing

410011

The Second Xiangya Hospital of Central South University, Changsha

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

510091

Dermatology Hospital of Southern Medical University, Guangzhou

510180

Guangzhou First People's Hospital, Guangzhou

510260

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

515041

The First Affiliated Hospital of Shantou University Medical College, Shantou

518026

Shenzhen Children's Hospital, Shenzhen

650032

First Affiliated Hospital of Kunming Medical University, Kunming

271-0092

Miyata Dermatology Clinic, Matsudo

734-0023

Shirao Clinic of Pediatrics and Pediatric Allergy, Hiroshima

070-0810

Motomachi Dermatology Clinic, Asahikawa-shi

066-0021

Chitose dermatology and plastic surgery clinic, Chitose Shi

080-0013

Takagi Dermatological Clinic, Obihiro

674-0068

Yoshimura Child Clinic, Akashi

658-0082

Iryouhoujinshadan Yamayurikai Tsujino. Kodomo Clinic, Kobe

221-0825

Nomura Dermatology Clinic, Yokohama

861-3101

Noguchi Dermatology Clinic, Kamimashiki-gun

572-0838

Yoshioka Dermatology Clinic, Neyagawa

593-8324

Kume Clinic, Sakai

120-0034

Mildix Skin Clinic, Adachi-ku

158-0097

Yoga Allergy Clinic, Setagaya-ku

170-0002

Sugamo Kobayashi Derma Clinic, Toshima-Ku

Sugamo Sengoku Dermatology, Toshima-Ku

814-0171

Hoshikuma Dermatology・Allergy Clinic, Fukuoka

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY